Organovo Holdings, Inc. (0R02.L)

USD 0.38

(-3.43%)

Long Term Debt Summary of Organovo Holdings, Inc.

  • Organovo Holdings, Inc.'s latest annual long term debt in 2023 was 888 Thousand USD , down -32.37% from previous year.
  • Organovo Holdings, Inc.'s latest quarterly long term debt in 2024 Q1 was 775 Thousand USD , down 0.0% from previous quarter.
  • Organovo Holdings, Inc. reported annual long term debt of 1.31 Million USD in 2022, down -22.95% from previous year.
  • Organovo Holdings, Inc. reported annual long term debt of 1.7 Million USD in 2021, down 0.0% from previous year.
  • Organovo Holdings, Inc. reported quarterly long term debt of 888 Thousand USD for 2023 FY, down -32.37% from previous quarter.
  • Organovo Holdings, Inc. reported quarterly long term debt of 1.1 Million USD for 2023 Q2, down -8.68% from previous quarter.

Annual Long Term Debt Chart of Organovo Holdings, Inc. (2023 - 2010)

Historical Annual Long Term Debt of Organovo Holdings, Inc. (2023 - 2010)

Year Long Term Debt Long Term Debt Growth
2023 888 Thousand USD -32.37%
2022 1.31 Million USD -22.95%
2021 1.7 Million USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 5000.00 USD -70.59%
2012 17 Thousand USD 0.0%
2010 - USD 0.0%

Peer Long Term Debt Comparison of Organovo Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
Xeris Biopharma Holdings, Inc. 190.93 Million USD 99.535%
Arrowhead Pharmaceuticals, Inc. 104.6 Million USD 99.151%
Codexis, Inc. 12.24 Million USD 92.747%
Viridian Therapeutics, Inc. 20.2 Million USD 95.605%